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Abstract: This article is based on semistructured interviews and focus groups conducted with 
27 asthma patients in The Netherlands who chose complementary and alternative medicine 
(CAM) for treatment of their condition. All subjects were contacted through an online forum 
for asthma patients hosted by the Dutch Asthma Foundation. Nineteen subjects (12 women and 
seven men) between the ages of 29 and 65 years participated in the interviews, held between 
June 2009 and January 2010. All of the participating subjects had experience with conventional 
medications, including anti-inflammatory corticosteroids and bronchodilators. For the focus 
group meeting, held in February 2010, the sample included seven subjects (four women and three 
men) between the ages of 31 and 46 years, none of whom had ever used conventional medication 
and all of whom were using CAM. All subjects in the sample had been diagnosed with asthma 
by their physician or lung specialist. The study examined the causes of patient noncompliance 
with the prescribed medical regime. It is argued that evidence-based rationality on the part of 
subjects is an overlooked dimension of their experience of asthma. This study demonstrates the 
role that the patients’ social network, including medical practitioners, friends, and family, and 
other asthmatics, plays in the process of decision-making and choices about treating asthma. It 
also demonstrates the role of patients’ information-searching strategies. The author concludes 
that patient noncompliance with commonly prescribed medication and selection of alternative 
medical treatment is less a matter of denial of their diagnosis or the severity of their illness, but 
more a matter of choice informed by evidence-based rationality.
Keywords: asthma, complementary alternative and medicine (CAM), evidence-based 
medicine (EBM), patient non-compliance, decision-making, indentity
Introduction
One of the most significant features of the prevailing Western medical paradigm is 
its growing reliance on scientific evidence. The movement towards evidence-based 
medicine (EBM) was a response to concerns about variations in quality of care, 
the rapid growth of medical technology, the patient empowerment movement, and 
psychologic research that raised questions about the quality of human judgment and 
decision-making.1 The central tenet of EBM is that, when making decisions about the 
care of patients, physicians should integrate their individual clinical expertise with 
the best available evidence from systematic research. EBM categorizes different types 
of clinical evidence and ranks them according to strength of proof. The strongest evi-
dence for therapeutic interventions is provided by a systematic review of randomized, 
double-blind, placebo-controlled trials involving a homogeneous patient population 
with a specific disorder.2 In contrast, patient testimonials, case reports, and even expert Patient Preference and Adherence 2010:4 submit your manuscript | www.dovepress.com
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opinion, have little value because of the placebo effect, the 
biases inherent in observation and reporting of cases, and the 
difficulties in ascertaining who is an expert.3
Current clinical guidelines have the aim of guiding and 
standardizing medical decision-making regarding diagnosis, 
management, and treatment in specific areas of health care. 
Such documents have been in use throughout the history of 
medicine. However, in contrast with previous approaches, 
which were often based on tradition or authority, modern medi-
cal guidelines are typically based on the paradigm of EBM.
Advocates of EBM have welcomed the stronger scien-
tific foundation of clinical guidelines, while critics fear that 
they will lead to “cookbook medicine”, with the clinician as 
sole decision-maker.4 This fear has been echoed by David 
Sackett, the founder of the Oxford Centre for Evidence-based 
  Medicine. In a series of articles, he pointed out that the 
concept of EBM was being widely misinterpreted through 
an almost exclusive reliance on evidence from randomized 
clinical trials for the determination of treatment and care 
regimens, and the abandonment of the collaborative practice 
of knowledge sharing between doctors and patients.5
Over the past 40 years, there has been a sharp increase 
in the global prevalence of asthma, particularly in children, 
as well as in the morbidity, mortality, and economic burden 
associated with the disease.6 Currently, there are approxi-
mately 300 million people worldwide who have asthma.7 The 
treatment of asthma has been an early target for standardiza-
tion via clinical guidelines.4 As some of the older tenets of 
asthma treatment were revised,8 easily identifiable “wrong” 
old practice still existed side by side with better, “updated” 
expert practice. Guidelines were seen as an instrument for 
keeping physicians updated and guiding them towards better, 
evidence-based practice. After publishing a first set of clini-
cal guidelines for the diagnosis and management of asthma 
1997, the National Heart, Lung, and Blood Institute of the 
US National Institutes of Health issued updated guidelines 
in 2002 and 2007. However, the overall effect of clinical 
guidelines for asthma is mixed and disappointing, consider-
ing the stakes in terms of both health and spending. Interna-
tionally, asthma treatment continues to be characterized by 
“unacceptable” treatment variation, despite the availability 
of guidelines.9,10
Current guidelines contain no clear direction for the use 
of CAM therapies for asthma, but an increasing number of 
patients are nevertheless opting for this treatment.11 The driv-
ing question behind this study is why some asthma patients 
choose noncompliance with recommended conventional 
Western medicine and turn instead to CAM therapies.
What is known about CAM  
and asthma alternatives?
EBM relies mainly on evidence gathered from systematic 
reviews of randomized controlled trials. Although the num-
ber of randomized controlled trials on CAM has increased 
in recent decades12 the Cochrane Library indexes only one 
review examining the effect of CAM in the management 
of asthma.11 Only two of the 15 reviewed studies showed a 
positive effect of CAM on asthma outcomes. The review’s 
most important conclusion is that “… more research is needed 
to assist in determining the efficacy of CAM therapies in 
asthma management”.
Nevertheless, in many Asian and Western cultures, 
herbal therapies are commonly used for asthma. Despite an 
improved understanding of the pathophysiology of asthma, 
well established standards of practice, advanced therapies, 
and available pharmaceuticals, parents of asthmatic children 
may augment their child’s conventional asthma medication 
with various CAM therapies.13,14 CAM use is indeed wide-
spread among children, because their parents are seeking a 
cure for asthma, as well as alternative methods that are natural 
and without long-term side effects.15–17
Traditional Chinese medicine (TCM), used in Asia for 
centuries, has come to play a role as a CAM modality in 
Western health care. There is increasing scientific evidence 
supporting the use of TCM for asthma treatment. A review 
article by Li and Brown18 discusses promising TCM inter-
ventions for asthma and explores their possible mechanisms 
of action. The authors reviewed five clinical studies of 
antiasthma TCM herbal remedies and on the basis of the 
data in the publications, summarized possible mechanisms 
underlying their effects, such as anti-inflammatory proper-
ties, inhibition of airway smooth muscle contraction, and 
immunomodulation. The authors concluded that evidence 
from clinical studies supports the beneficial effects of TCM 
herbal therapy in asthma. A number of mechanisms may be 
responsible for the efficacy of these agents, and these need 
to be addressed in future research.18
Li and Brown18 identified three clinical studies involving 
children using traditional Chinese antiasthma medications. 
These included several preparations, including modified mai 
men dong tang (mMMDT, consisting of five herbs), ding 
chuan tang (nine herbs), and STA-1, consisting of a combi-
nation of mMMDT and lui wei di huang. In all three studies, 
the subjects continued their prescribed conventional medical 
regimen, but the treatment group was given a TCM formula 
and the control group was given a placebo. The treatment 
group demonstrated an improved forced expiratory volume Patient Preference and Adherence 2010:4 submit your manuscript | www.dovepress.com
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compared with controls in all three studies. All participants 
were able to tolerate the TCM formulas well. In another study 
utilizing the principles of TCM, sanfujiu (a paste   consisting 
of five Chinese herbs) was applied to treat   allergies and 
asthma by increasing yang qi (“nature of the sun” heat) in the 
lungs.17 This study included 119 subjects of all ages. Those 
with asthma were more likely to report that the   sanfujiu 
treatment was effective than subjects who had other allergic 
diseases.
Stockert et al19 examined the effectiveness of a combi-
nation of laser acupuncture and probiotics in the treatment 
of asthma. A small group of 17 children participated in 
a randomized, placebo-controlled, double-blind study of 
TCM in asthmatic children. Laser acupuncture was substi-
tuted for needle acupuncture, and probiotics derived from 
  nonpathogenic Enterococcus faecalis were administered 
in place of the TCM herb, jin zhi. The control group was 
treated with a laser pen and given placebo drops to ingest. 
The results of this study demonstrated that the treatment 
group had significantly decreased bronchial hyperreactivity, 
as indicated by decreased weekly peak flow variability.19 
In addition, a recent study by Wei and Gong20 shows that 
acupuncture can also have a remarkable effect in stopping 
an acute asthma attack.
Arnold et al21 have reviewed studies of the efficacy and 
safety of herb- and plant-based preparations for the treatment 
of asthma. The authors concluded that the evidence base for 
the effects of herbal treatments is hampered by the variety 
of treatments assessed, poor reporting of results, and a lack 
of available data. However, according to the investigators, 
some findings from the reviewed studies were positive and 
warrant additional, well-designed trials.
An important part of the assessment of CAM modalities 
is the therapeutic-toxicologic safety profile (risk-benefit 
ratio), and further research evaluating the clinical effi-
cacy and mechanism of action of various CAM interven-
tions for asthma is greatly needed.22 Li and Brown18 and 
  Mainardi et al23 have summarized the difficulties of testing 
  biologically-based TCM modalities, pointing out that isola-
tion and identification of active constituents may be difficult 
because of the nature of the herbs and of manufacturing and 
preparation processes; the synergistic effect of herbal combi-
nations complicates the ability to determine the exact effect; 
TCM formulas are traditionally created for the individual, 
and standardization of TCM may not be effective; random, 
blinded studies are difficult to conduct when the subject’s 
perception of CAM therapies may influence the results; and 
there is a need for more controlled clinical trials to test the 
efficacy of TCM formulas.18,23 An additional hypothesis 
to explain the lack of conclusive evidence of the efficacy 
and safety of CAM is that the type of funding may have 
biased the design of studies and interpretation of findings.24 
Funding by the pharmaceutical industry is associated with 
design features that are less likely to lead to the discovery 
of statistically significant adverse effects of conventional 
drugs, such as inhaled corticosteroids, and to more favor-
able clinical interpretations of such findings. It has also been 
recommended that disclosure of conflicts of interest should 
be mandatory for a more balanced opinion in the reporting 
of drug safety studies.25
Patient noncompliance
The issue of compliance with prescribed medication   regimens 
has traditionally been dominated by the perspective of the 
health professional. Increasingly, however, medical anthro-
pologists and sociologists have started to present the patient’s 
point of view.
Evans and Spelman26 argue that the patient’s level of 
compliance is influenced by psychologic factors, such as 
anxiety, motivation to recover, attitude towards the illness, 
the drug and the doctor, as well as the attitudes and beliefs 
of significant others. The authors conclude that, contrary to 
widespread medical belief, the evidence do not support the 
view that medication noncompliance is a deviant form of 
behavior influenced by patient characteristics.
M hlhauser and Lenz’s study27 of noncompliance 
  suggests that it is rarely provoked intentionally or by lazi-
ness, concluding that patients should not be the first to be 
blamed for lack of therapeutic success. Noncompliance on 
the part of health care providers when supplying patients 
with necessary information and skills is also an important 
cause of poor treatment outcomes. Patient knowledge, when 
evidence-based and relevant to the patient, can enable patients 
to assume an important part in their disease management. 
This can improve health outcomes, although it may lead 
to intelligent noncompliance and a worsening of treatment 
outcomes according to conventional assessment criteria.
Some studies have linked patients’ treatment decisions 
to their identity. In their study of asthmatics, Adams et al28 
argue that asthma patients’ noncompliance with (Western) 
medical regimens is a matter of patient denial of their identity 
as an asthmatic. Beatty and Joffe29 argue that chronic illness 
can cause a dramatic shift in an individual’s identity, lead-
ing to a reassessment of the self and life goals, and that the 
symptoms of illness lead to physical and emotional changes 
that affect the sense of self. Responses from others may also Patient Preference and Adherence 2010:4 submit your manuscript | www.dovepress.com
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influence a person’s self-esteem. People with a   long-term 
illness must reinterpret their future in light of possible limita-
tions. The psychologic project to be resolved in this new life 
stage revolves around adapting to and coming to terms with 
the new self. De Ridder et al30 further discuss the physiologic, 
emotional, behavioral, and cognitive aspects of psychologic 
adjustment to chronic illness. They conclude that patients 
should remain as active as is reasonably possible, acknowl-
edge and express their emotions in a way that allows them 
to take control of their lives, engage in self-management, 
and try to focus on potential positive outcomes of their 
illness. Patients who can use these strategies have the best 
chance of successfully adjusting to the challenges posed by 
a chronic illness.
Scherman and Lowhagen31 conducted a longitudinal 
qualitative study describing asthma/allergy patients’ expe-
riences of medication. Three categories were identified, 
ie, “access to medicine is important to relieve discomfort 
and to avoid fear”; “medicine damages your body and your 
identity without curing the illness” (because “you can become 
immune or addicted”, “the ability of your body to heal itself is 
weakened”, “your body’s own signals are camouflaged”, and 
“you become stigmatized”), and “production and distribu-
tion of medicine is a profit-seeking commercial undertaking 
which is not primarily aimed at curing the patient”. Medi-
cation experiences were stable over time. It was concluded 
that sociologic and biologic survival must be compared in 
open discussions with the patient’s and health professional’s 
different reasons for how they take or prescribe medication, 
respectively.
Telford et al32 explored the terms of acceptance and 
denial with the aim of categorizing people’s responses to 
living with chronic illness. They note that the chronically ill 
may be labeled by others as being in denial of their illness or 
indeed their identity as chronically ill persons, particularly 
when they do not adhere to prescribed treatments. According 
to this study, health care professionals commonly refer to the 
terms “acceptance” and “denial” when describing a person’s 
response to chronic illness. Health care providers who use 
this acceptance-denial framework may not be able to listen 
when people with chronic illness attempt to tell their own 
unique story of how they have experienced life with illness. 
Instead, their listening antennae may be focused on fitting 
aspects of the patient’s experience to stages of acceptance or 
denial. When others use the labels of acceptance and denial, 
people who are learning to live with a chronic illness may 
internalize these labels as a reflection of the self. This may be 
most likely when the person using the label is perceived to be 
an authority, such as a health care professional. The authors 
urge health care professionals to challenge the stage model 
of adjustment as a way of understanding the response to 
  illness and to listen instead to the stories people tell in 
order to privilege the person’s experience as the basis for 
  developing a sensitive response that takes into account the 
wider social context of people’s lives, in addition to the 
medical aspects.
Information sources  
and   decision-making
Medical sociologists have argued that it is simplistic to 
believe that when patients make decisions about their treat-
ment they are blindly led by their physician and that they 
do not renegotiate the use of drugs according to their own 
judgment. Non-compliance with medical regimens can be 
better explained by the rational accumulation of information 
by the patient from his/her entire network, in addition to 
information received from medical “experts”.33 According 
to the school of symbolic interactionism, people’s reac-
tions to drugs are mediated by the beliefs, expectations, 
and knowledge they have acquired through interaction with 
other people and by previous experiences.34,35 Drug-taking 
activities are structured by a social context in which the drug 
user is told by drug-using peers what physical or psychologic 
sensations to expect and how to recognize their effects.36 In 
the case of prescription drugs, it is the prescribing doctor, 
not peers, who relays drug information to the user and acts 
as an authority figure regarding the effects (or side effects) 
of the drugs. However, in our society, people tend to receive 
information about what they might do about their health from 
many different sources, including family members, friends, 
and the media. They take this information into account in 
assessing their need for medical treatment. In this sense, 
people’s social relationships have a bearing on their health-
related behavior.35
The use of the Internet for finding health and disease 
information is widely acknowledged.37 Patient empowerment 
has also led to greater skepticism about advice from doctors, 
and in some cases has undermined the dominant medical 
paradigm and supported CAM.38
Case study
This article is based on a small-scale qualitative study of 
26 asthmatics selected through Astma Fonds,39 a platform for 
Dutch asthma patients. Written consent was obtained from 
this group, and the results of the study were forwarded to the 
interview and focus group participants. Consent to publish Patient Preference and Adherence 2010:4 submit your manuscript | www.dovepress.com
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the results was obtained from all participants. Semistructured 
interviews were conducted with 19 subjects who had used 
conventional medicine at least once prior to selecting CAM or 
who continued to use CAM simultaneously with conventional 
medication. The sample included 12 women and seven men 
between the ages of 29 and 65 years, who were selected on 
the basis that they had been officially diagnosed with asthma 
by a physician, were noncompliant with the drug regimen 
prescribed by their physician or lung specialist, and used 
CAM, such as TCM, Ayurvedic medicine, herbal therapy, 
acupuncture, yoga, homeopathy, chiropractic medicine, and/
or massage therapy. Of the total sample, 15 patients had used 
prescribed medication prior to their switch to CAM, and eight 
still occasionally resorted to it (in combination with CAM). 
Four subjects, having been diagnosed with asthma by their 
physician, never complied with the prescribed medical regi-
men. Of these, three consulted an alternative practitioner, and 
one did not consult any practitioner, relying instead on “self-
medication” (a combination of alternative treatments) since 
the time of diagnosis. The most common type of medication 
used was TCM, used by 11 subjects, followed by homeo-
pathic medication, used by four subjects, and Ayurvedic 
medicine, used by two subjects (both of whom combined it 
with yoga and other therapies). The two remaining subjects 
used a combination of methods, consisting of herbal and 
chiropractic medicine, as well as massage therapy. TCM was 
reported to be the most successful (nine of 11 TCM users 
were satisfied with the results), followed by homeopathic 
medicine (two of four subjects were fully satisfied).
Semistructured individual interviews were recorded and 
transcribed between June 2009 and January 2010. In 17 cases 
the interviews were recorded once, while two interviewees 
volunteered for a second session because they felt that the 
initial interviews needed to be supplemented with additional 
information. Initial interview questions were directed at 
patients’ experiences related to their selection of CAM, 
based on four main forms of encounters, ie, the patient’s 
own illness and identity as an asthma patient, with medical 
practitioners (family physician, lung specialist), available 
information on disease and medical treatments from sources 
including online and printed media, and information and 
advice from patients’ social groups (patient organizations, 
family, peers, etc.). Additionally, all 19 participants were 
asked to supply additional information, such as prescription 
details and printouts of online sources related to asthma 
medication. In addition to the interviews, a focus group 
meeting was held with the seven subjects who had never 
used conventional medication. Focus group themes centered 
on the four encounters described above, with an additional 
theme focusing on CAM. The focus on CAM was broken 
down into specific questions addressed to the group by the 
moderator, ie, what type of CAM treatment the subjects use, 
what encounter (with medical practitioners, a social group, 
online sources, etc) or combination of encounters was most 
important in determining this choice (if any), and experiences 
with the use of CAM, including the patient’s own experi-
ences and anecdotal evidence. Thematic analysis was used 
for evaluating the results of this session.
Data from the semistructured interviews and the 
focus group sessions were transcribed and the qualitative 
data analysis program MAXQDA (http://www.maxqda.
com/maxqda-eng/index.htm) was used for data analysis.
Perception of illness  
and patient identity
Interview questions related to the subjects’ experience of 
asthma and their own identity included those associated 
with the asthma symptoms experienced, as well as patient 
acceptance or denial of their condition. It appeared that most 
subjects in the sample did not deny their identity as asthmatics 
nor underplay the severity of their symptoms. While one of 
the subjects described her symptoms as “acute” rather than 
chronic, she noted that the acute periods “sometimes do come 
back,” although she could not detect any specific patterns, 
such as environmental stimuli or triggers. The majority of 
the subjects in the sample (n = 15) acknowledged that they 
“had asthma” and “were asthmatic”, while four subjects 
stated only that they “had asthma” and preferred not to “stick 
the sickness label” on themselves, as one of the subjects 
described it. Most of the subjects (n = 17) agreed with the 
doctor’s diagnosis of asthma, although two subjects referred 
to the diagnosis made by the alternative practitioner (Chinese 
or Ayurvedic practitioner), as a “disease of the lungs” or an 
“imbalance”. These two subjects however, had combined 
both the Western practitioner’s diagnosis and that of the 
alternative practitioner.
Among those interviewed, seven subjects experienced 
their asthma as something they should not discuss in public 
or at work due to the possible stigma of “being sick” or, as 
one patient put it, a “sign that you’re growing old”. However, 
all subjects except for two felt that it is “something that has 
to be dealt with” and “cannot be left untreated”. One patient 
remarked, self-deprecatingly, “Well, I just hope it will go 
away”.
During the focus group session, the theme of negative 
stereotyping was expanded, with four of seven participants Patient Preference and Adherence 2010:4 submit your manuscript | www.dovepress.com
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referring to “stigma”, “being pigeon-holed”, or “exclusion” 
as some of the aspects of their experience of being asthmatic. 
One example cited was the law banning smoking in public 
spaces. Dutch legislation imposed a smoking ban in all 
public places beginning in the summer of 2008 which has 
subsequently loosened under public pressure. Small cafes in 
particular refused to comply with the smoking ban in 2008, 
a trend that spread to larger cafes and to bars in 2009. Sub-
jects reported that, despite their protests to café owners, bar 
personnel, and smokers themselves, their complaints were 
largely dismissed. Describing such encounters, two subjects 
felt relegated to the category of “a sick person” who “should 
not be going (to cafes) in the first place”. Both indicated that 
cigarette smoke caused them to experience asthma symptoms 
and felt that their “sick” label was deserved, but described 
the behavior of bar personnel as “arrogant” and “incon-
siderate”. All seven participants referred to themselves as 
“asthmatic” but did not necessarily see asthma as a chronic 
or incurable condition. In addition to seeing themselves as 
asthmatic, three referred to themselves as suffering from an 
“imbalance”, referring to a holistic identification of illness 
common to CAM.
Encounters with medical 
practitioners
Experiences with medical practitioners varied greatly, from 
being confronted with a “very knowledgeable and attentive 
physician” to a “self-assured, know-little, so-called special-
ist”. In the latter negative case, three of six subjects sought a 
second opinion, and two evaluated the second practitioner as 
being better than the first. An overwhelming feeling among 
those who had consulted physicians on multiple occasions 
(n = 11) was that the physician was “very convincing” and 
“quite insistent” about the use of medicines containing 
budesonide (a corticosteroid) and/or formoterol (a long-
acting β2-agonist).
Alternatives were not discussed, except when subjects 
initiated the discussion themselves. In one case, the doc-
tor’s reaction to a patient’s question about alternatives was 
“But why?” When the patient responded that she was afraid 
of the long-term effects of Symbicort®, the doctor asked 
“What effects?” The exchange went on, with the patient 
insisting that she had read studies indicating that there are 
apparent risks, and the doctor insisting that “all medicines 
have risks” and that she was not aware of any risks with 
long-term use of Symbicort. When the patient produced 
the prescription drug warnings included with her medicine, 
the doctor suggested alternatives (all of which contained 
budesonide and formoterol). When asked about alternative 
medicine, such as Ayurveda, the doctor, according to the 
patient, shrugged and replied that “These are not real alterna-
tives”. The patient insisted on getting a second opinion and 
was referred to a lung specialist, who agreed with the family 
physician that the only adequate treatment was medication 
containing budesonide and formoterol. At this stage, the 
patient acknowledged her desire to seek an opinion from an 
alternative practitioner. The doctor asked the patient not to 
stop taking the prescribed medication while using alterna-
tives, with the patient retorting that the effects of alternative 
medicine would not be known unless she stopped using 
conventional medication. The doctor then suggested that use 
of complementary medicine (rather than the exclusive use of 
alternative medication) would be a good compromise. The 
patient reflected that it would only be a good compromise 
for the doctor herself, since by allowing the use of alterna-
tive medicine in a “complementary” way, the doctor made 
sure that the patient stayed on “safe and proven” allopathic 
medicine. According to the patient, the doctor tried to “trick 
her”, refused to take her concerns seriously, and “completely 
discounted the possibility of the effectiveness of alternative 
medication when taken on its own”.
Another patient related a story about an encounter with 
her doctor, who was aware of the long-term risks of the medi-
cation but considered them to be “the lesser of two evils”, 
implying that if the asthma was left untreated, the patient 
will have a greater risk of death in the long term. The patient 
replied that she did not intend to leave her asthma untreated; 
rather, she was looking for alternatives to what she considers 
to be a “heavy medicine”. The patient then mentioned her 
age of 29 years and that if she took her medication continu-
ously as prescribed, by the age of 50 she “might be dead”. 
To this, the doctor, according to the patient, became “really 
upset” and talked to her “like she was a small, stubborn 
girl”, speaking very slowly and distinctly, indicating that 
the patient’s concerns were “irrational”. The patient went 
for a second and third opinion and while she encountered 
“more open-minded specialists”, she felt that her fears were 
not taken seriously.
In another case, a male patient with severe long-standing 
asthma (untreated for at least five years) revealed that his 
encounter with a doctor resulted in him “walking out of 
the doctor’s office” because the doctor “blamed (him) for 
not coming in earlier”, for “continuing to smoke while 
knowing it is bad”, and for “not taking her (the doctor’s) 
opinion seriously”. The patient felt insulted by the doctor’s 
“arrogant attitude” and “complete lack of understanding”. Patient Preference and Adherence 2010:4 submit your manuscript | www.dovepress.com
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  However, the second doctor consulted by the same patient was 
“  well-informed” and “respectful” and suggested   treatment in 
combination with lifestyle changes (quitting smoking). While 
the patient followed the recommendation and   managed to quit 
smoking, he became concerned about the side effects of the 
prescribed medication and contacted the same doctor again 
with questions about alternatives. The doctor actually sug-
gested that the patient should consider alternative medicine, 
while warning him that “to the extent of his knowledge”, 
commonly prescribed medications “work best”. The doctor 
suggested, however, that he did not recommend alternative 
medications himself, and that if the patient chose alternative 
methods, he “will need to keep himself very well informed” 
and would be choosing CAM treatment “at his own risk”.
While the first two subjects felt that they were perceived 
as “ill-informed”, “stubborn”, and “irrational” by the doctors 
they consulted, most subjects in this sample had an experi-
ence similar to the last patient described. The majority of 
doctors encountered by the subjects in the sample insisted that 
prescribed medication “works best” or is the “most proven” 
method of controlling asthma. Doctors were not always 
adamant about discouraging patients to seek information 
about alternatives, but expected that use of alternative treat-
ment would not lead to positive results. Doctors’ opinions 
about CAM, according to subjects, varied from viewing it 
as a “quack trade” to being “a viable alternative, perhaps, 
although not well studied … yet”.
The focus group session described similar experiences 
to those in the group of exclusive CAM users, with the 
significant difference being that their opinion of the medi-
cal practitioners’ expertise was very low. One patient in 
the group felt that “none of the doctors” she has consulted 
had any respect for her concerns. This was echoed by two 
other women in the group, who considered that the doctors 
might have attributed their concerns to “female whims” or 
“hysteria”. This opinion was offset by the only male in the 
group, who said that his experience with doctors was just as 
humiliating and had nothing to do with gender.
Printed and online information
All of the subjects in the interview sample who have tried 
prescribed medication (n = 15) indicated that they read 
the instructions for use enclosed in the package. Nine 
subjects also consulted online information about the drug 
prescribed for them; a further five read articles related to 
their medication. Most subjects (n = 17) consulted the 
Internet to find out about the risks and benefits of their 
prescribed medication. Of these, 10 consulted Dutch 
  language sources only. Five consulted printed sources, 
such as books and articles from a library. The most com-
mon research subject was the possible side effects and 
risks of the prescribed medication. Other subjects included 
correct use, other patients’   experiences, chemical compo-
sition and properties of the medicine, and research on the 
use of the medicine. One patient described his experience 
with online sources:
“First, I was overwhelmed by the amount of data 
(on the Internet). Then, I was even more overwhelmed by 
the amount of conflicting data. And the advice people give 
(online) … some say ‘use it’, others say ‘no, never, it’s dan-
gerous!’ … from what I could gather, it was clear that there 
is no agreed-upon opinion … ”
This quote is quite typical of the responses from 
those interviewed, with most of them indicating that they 
encountered confusing data, some having “problems with 
  understanding the (medical) jargon” and having trouble 
deciding which sources are “most reliable”. However, most 
of them indicated that on the basis of the information they 
found, they were able to make “an informed choice”.
Supplementary information  
from patients
The following information was provided by the subjects 
themselves. Ten indicated that the controversy around the 
safety of medicines containing budesonide and/or formoterol 
has been “particularly disturbing”. As one of the subjects 
eloquently put it, referring to the others participating in the 
study, “but then of course, we’re all skeptical asthmatics”. 
Another said “Well, that’s what you get with selection bias”. 
The same subject supplied a collection of articles indicating 
that the use of preventive drugs for asthma is associated with 
potentially severe side effects. Most of the articles referred 
to studies of preventive medications containing budesonide 
and formoterol. One of the articles provided by the same 
asthmatic was by Nieto et al25 who argue that independently 
funded studies of inhaled corticosteroids are up to four times 
more likely to find adverse effects than studies paid for by 
drug companies.
Another set of articles provided by the same subject 
addressed medical statistics. Salpeter et al asserted that clini-
cal trials demonstrate that the long-acting β2-agonists cause 
a statistically significant number of deaths when compared 
with patients taking placebo.40 This research, published in 
2006, found that long-acting β2-agonists increased the risk 
for asthma hospitalizations and asthma deaths by two- to 
four-fold compared with placebo.40,41Patient Preference and Adherence 2010:4 submit your manuscript | www.dovepress.com
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Online sources available to the subjects, who supplied 
them to the researchers, included information about warn-
ings on the medication label for Symbicort, the drug most 
subjects in this study were prescribed (n = 9), indicating a 
risk of asthma-related death (see case study at the end of this 
article). One subject brought in the prescribing information 
with underlined passages from the warnings:
“A 28-week, placebo-controlled US study comparing 
the safety of salmeterol with placebo, each added to usual 
asthma therapy, showed an increase in asthma-related deaths 
in patients receiving salmeterol (13/13,176 in patients treated 
with salmeterol vs 3/13,179 in patients treated with placebo; 
relative risk 4.37, 95% confidence interval 1.25, 15.34). The 
increased risk of asthma-related death may represent a class 
effect of the long-acting beta2-adrenergic agonists, includ-
ing formoterol. No study adequate to determine whether the 
rate of asthma-related death is increased with Symbicort has 
been conducted”.
A patient who normally resided in the US supplied the 
US prescribing information enclosed with Advair Discus® 
  containing fluticasone (a corticosteroid) and salmeterol 
(a long-acting β2-agonist). Data from a large placebo-
  controlled US study that compared the safety of salmeterol 
or placebo added to usual asthma therapy showed an increase 
in asthma-related deaths in patients receiving salmetorol 
(13 deaths in 13,176 patients treated for 28 weeks on salme-
terol versus three deaths in 13,179 patients on placebo).
Another patient supplied a link to a website (http://www.
rxlist.com/symbicort-drug.htm) with information on a recent 
meta-analysis of the roles of long-acting β2-agonists, indicat-
ing that they may pose a danger to asthma patients. Long-
acting β2-agonists may increase the risk of asthma-related 
death. Data from a large placebo-controlled US study that 
compared the safety of salmeterol or placebo added to usual 
asthma therapy showed an increase in asthma-related deaths 
in patients receiving salmeterol. This finding with salmeterol 
may apply to formoterol (β2- agonist), one of the active ingre-
dients in Symbicort. Clinically significant cardiovascular 
effects and fatalities have been reported in association with 
excessive use of inhaled sympathomimetic drugs.
All 19 subjects researched CAM through a combina-
tion of printed and online sources, complemented by 
online patient forums (such as Astma Fonds and alternative 
medicine forums). The opinion of an overwhelming num-
ber (n = 17) of the subjects was that alternative medicines 
seemed “less threatening”, and that there were “no appar-
ent risks”. While the data were also conflicting and patchy, 
most subjects felt that “once you’ve found the right source” 
(ie, a source they could trust) it was “easy to navigate” and 
“find information”. Criteria for choosing “the right source” 
differed greatly from patient to patient. Most sources viewed 
as reliable originated from established or well-known medi-
cal institutions, or included research done by “specialists” 
(by which some subjects meant health practitioners, while 
others meant medical researchers). Evidence from others, 
especially if gleaned from online forums (five subjects con-
sulted international rather than Dutch forums) was also rated 
high on the reliability scale.
Encounters with subjects’  
social groups
In addition to information obtained from practitioners or 
discovered by subjects themselves in printed and/or online 
sources, social networking served as an information source, 
albeit to a more limited extent. In most cases, subjects con-
sulted close relatives and friends rather than extended family 
members or colleagues. Eight subjects reported receiving 
advice from other asthmatics, notably through Astma Fonds. 
Fellow asthmatics constituted a group whose “opinions were 
valued” or whose advice was sought as a complement to 
other sources of information. Opinions and advice given by 
family, friends, and fellow asthmatics differed greatly with 
regard to prescribed medication, patient decisions about 
compliance, and CAM.
The most important source of information about asthma 
medication for the focus group participants was friends, fam-
ily members, or fellow asthmatics whose use of CAM had 
been beneficial. Despite the fact that all seven participants 
in the sample were discouraged from using CAM by their 
doctor, there was abundant anecdotal evidence of success in 
curative terms, rather than preventive or symptom-relieving 
treatment. During the discussion, participants stated that 
while conventional asthma medications were geared towards 
relieving the symptoms of asthma, preventing their exacer-
bation, and preventing asthma attacks, they were not pre-
sented as “curing” asthma. All seven discussion participants 
stated their belief that medical practitioners (one patient 
included the “pharmaceutical industry” and “insurance 
companies”) insist that asthma is “chronic” and “incurable” 
by definition. The subjects reported the experiences of other 
asthma sufferers (friends, family members, or members of 
online forums), as well as the views of CAM practitioners 
(including TCM or Ayurveda) who maintain that asthma 
is not necessarily “incurable”. All seven participants men-
tioned that they “knew people” in their immediate social 
circle who were “cured of asthma” or at least no longer had Patient Preference and Adherence 2010:4 submit your manuscript | www.dovepress.com
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asthma symptoms. When the moderator asked about how 
long these contacts had been symptom-free, and whether 
the symptoms had disappeared altogether, the responses 
were inconclusive.
Another important aspect of the positive experiences 
reported by the group using CAM was the belief that “CAM 
has no serious side effects” and that it is “safe to use”. When 
the moderator asked subjects to elaborate on the evidence for 
this belief, the participants stated that “people they knew” had 
never reported any negative effects from TCM, Ayurvedic, 
or homeopathic treatments. The only reported side effect of 
the use of certain herbs in TCM treatment was “excessive 
urination” which participants laughed at and did not find 
threatening (“Not in comparison with heart attacks”, one of 
the participants said).
Results and discussion
The driving question behind this study was why some asthma 
patients decided not to comply with their prescribed medi-
cation regimens and choose to use CAM instead. We have 
explored whether the patients’ rights movement has led to 
a greater awareness of the benefits of alternative medicine. 
In the present study, we discovered that, on the whole, sub-
jects were well informed about the risks and benefits of both 
prescription and alternative medicines (see Table 1). While 
the risks of commonly prescribed medications (as revealed 
in the results of clinical trials) were particularly noted by 
the subjects, the benefits of CAM (not tested in clinical 
trials but based on anecdotal evidence) were emphasized. 
We argue that noncompliance with medical regimens by 
some asthmatics can be explained by the rationality of their 
choice, which is based on evidence from clinical trials of 
commonly prescribed asthma medications, as well as on 
partial and anecdotal evidence of the benefits of CAM. We 
also argue that it is the patients themselves who, by invoking 
the evidence-based dominant medical paradigm, choose to 
address the conflict between conventional Western medi-
cine and other modalities. Concerns about the side effects 
and long-term risks of conventional asthma medications 
motivated the patients to choose alternative treatment. We 
can conclude that noncompliance with prescribed medical 
regimens is less a matter of patient denial or acceptance of 
Table 1 Reasons given by patients for choosing CAM options to manage their asthma
Topic Interviews (n = 19) (Focus group n = 7) Discussion
Perception of illness  
and own identity
Most patients did not deny their  
identity as asthma sufferers nor  
underplay the severity of their  
symptoms. Stigma relating to the  
illness was resented.
All participants referred to  
themselves as “asthmatic” but  
did not necessarily see asthma  
as a chronic or incurable  
condition. Some referred to an  
“imbalance” in the system.
Most patients in the 
study (n = 24) referred to 
themselves as asthma sufferers, 
most  experienced the “stigma” 
of being seen as “sick”. Asthma  
was not necessarily seen as  
incurable.
Encounters with medical  
practitioners
Mixed experiences, in more than  
half of the cases patients  
requested a second opinion.
Mostly negative experiences,  
especially in relation to their  
noncompliance with a  
medication regime and use  
of CAM.
Focus group patients choosing  
to use CAM exclusively found  
little support from their  
physicians, while complementary   
users had more positive  
experiences.
Encounter with print  
and online information  
on asthma and medical  
treatments
The majority of patients  
demonstrated an awareness of the  
negative results of clinical trials of  
conventional medications; they  
were most concerned about  
controversies and potential risks.
All participants were aware of  
potential negative effects of  
conventional medicine. All were  
convinced that conventional  
medicine offers symptom relief  
only and that CAM is less  
dangerous and has the potential  
to “cure” asthma.
Most patients discovered  
significant risks in the long-term  
use of conventional medications.   
Alternative medicines were  
referred to as “less  
threatening”, and containing “no  
apparent risks” in comparison  
to conventional medicine. 
Encounter with  
patients’ social groups  
(patient organizations,  
family, peers, etc)
Mixed experiences. In most cases,  
close relatives and friends were  
consulted about medication  
choices rather than extended  
family or colleagues.
All participants consulted other  
patients who had experience  
with CAM. The anecdotal  
evidence of CAM’s success in  
treating asthma was of  
paramount importance in the  
decision not to use  
conventional medicine.
While the subjects interviewed  
based their decision mostly on  
limited exchanges with their  
close family and friends, focus  
group subjects relied mostly on  
information conveyed by other  
asthmatics using CAM.
Abbreviation: CAM, complementary and alternative medicine.Patient Preference and Adherence 2010:4 submit your manuscript | www.dovepress.com
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a diagnosis of asthma and its severity, but more a matter of 
rational choice informed by an awareness of evidence-based 
results. We refer here particularly to the patients’ awareness 
of the rather controversial results of clinical trials of com-
monly used asthma medicines, particularly those containing 
budesonide and formoterol.
These findings, if supported by more extensive study, 
may lead to some revision in medical decision-making. 
Because medical decision-making emphasizes the impor-
tance of evidence-based knowledge or judgment, a patient’s 
informed perspective may need to be considered as part of the 
overall evidence and therefore, as part of the basis for joint 
decision-making. We have, however, noted that integrating 
“alternative” patient perspectives may be difficult due to the 
dominance of “evidence-based” prescribing, the delivery of 
which is largely funded by governments (and by the pharma-
ceutical industry and insurance companies), and supported 
by a system of education in which alternatives are viewed as 
irrational, not evidence-based, useless, and even potentially 
dangerous. This can create a negative cycle in which CAM is 
not tested according to the standards of EBM because there 
is not enough evidence available to prove that some types 
of CAM can be indeed safe and effective in the treatment of 
asthma. Until systematic, large-scale studies of the safety and 
efficacy of CAM are conducted, asthma patients choosing 
CAM will continue to resort to anecdotal evidence.
It is remarkable that, at present, hardly any clinical tri-
als of CAM have been conducted. The results of this study 
demonstrate that a thorough investigation of the reasons 
behind Western medicine’s reluctance to engage in clinical 
trials of CAM is desired by patients. When these reasons 
(and particularly priorities in government spending) are 
outlined, clinical trials of CAM should lead to greater 
patient confidence and compliance with prescribed medical 
treatments for asthma. However, it should be acknowl-
edged that this paper reports a small case study and that 
the results cannot be generalized to the whole population 
of CAM users. This study, however, is a plea for further 
research into the issue of patients’ views of commonly 
prescribed asthma medication by professionals involved 
in the treatment of asthma, as well as for the provision of 
funding by relevant government, insurance, and pharma-
ceutical agencies.
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